Floatz logo

IRON(II) SULPHATE (1:1), HEPTAHYDRATE

Soft Tissue Cancer

Sichuan Enray Pharmaceutical Sciences CompanySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Soft Tissue Cancer cohort.

Asset / SponsorPhaseRating
Carbon Nanoparticle-Loaded Iron
Sichuan Enray Pharmaceutical Sciences Company
Phase 2CCC
Carbon Nanoparticle Suspension
Sichuan Enray Pharmaceutical Sciences Company
Phase 2CCC

Same molecule, other indications

IRON(II) SULPHATE (1:1), HEPTAHYDRATE is also rated in:

iron deficiency anemiaDormant
BBB
Indicative ·
75 / 100
View asset →
chronic kidney diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
restless legs syndromeDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →